Join
Live feed
·
NEWSReleasevia Quantisnow
Gracell Biotechnologies Inc. logo

Stifel Downgrades Gracell Biotechnologies to Hold, Lowers Price Target to $10.25

ByQuantisnow·Wall Street's wire, on your screen.
GRCL· Gracell Biotechnologies Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GRCL (Gracell Biotechnologies Inc.) and more on Quantisnow.